NCT06600009 - Treatment Persistence of Biologics in Patients with PsA in Japan; Retrospective Cohort Study Using a Claims Database | Biotech Hunter

Enrollment

534

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

August 21, 2023

Study Completion Date

September 15, 2023

Conditions

Psoriatic Arthritis

Interventions

DRUG

Secukinumab

Patients had received secukinumab per their dosing regimens prior to this observational study.

DRUG

Adalimumab

Patients had received adalimumab per their dosing regimens prior to this observational study.

Trial Locations (1)

Novartis Pharma K.K., Tokyo